Tactile Systems Technology Q1 2026 Earnings Call Summary
Tactile Systems Technology reported a revenue growth of 23% in Q1 2026, driven by improved sales operations and strategic initiatives. The company also announced the acquisition of Lymphotech to expand its lymphatic care solutions and updated its full-year revenue guidance between $360 million and $368 million.
Tickers: $NVDA
Topics: operational_performance product_launch revenue_growth strategic_acquisition